Medicamen Biotech Limited signs CDMO contract with XGX Pharma

Medicamen Biotech Limited has signed a contract for CDMO with XGX pharma, European company where Medicamen will develop 6 products and will do manufacturing of these products for European company. XGX will hold MA (Market authorisation).

Shares of MEDICAMEN BIOTECH LTD. was last trading in BSE at Rs. 485.20 as compared to the previous close of Rs. 494.55. The total number of shares traded during the day was 1687 in over 150 trades.

The stock hit an intraday high of Rs. 495.95 and intraday low of 480.05. The net turnover during the day was Rs. 824372.00.

Source : Equity Bulls

Keywords

MEDICAMENBIOTECH INE646B01010 Pharmaceuticals CDMO Contract XGXPharma